Sector revisions Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 23:00:00 07/08/2026 +03			5-day change	1st Jan Change
15.88 ^USD	+1.08%		-29.98%	+1.28%

08-06	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Earnings Flash (GLUE) Monte Rosa Therapeutics, Inc. Reports Q2 Collaboration Revenue $9.0M, vs. FactSet Est of $12.9M	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
MONTE ROSA THERAPEUTICS, INC.		6
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		21
IQVIA HOLDINGS INC.		18
BEONE MEDICINES AG		25
CELLTRION, INC.		24
ASCENDIS PHARMA A/S	-	18
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
ICON PUBLIC LIMITED COMPANY		16
BIO-TECHNE CORPORATION		11
ABIVAX		6
PRAXIS PRECISION MEDICINES, INC.		18
APOGEE THERAPEUTICS, INC.		12
PHARMARON BEIJING CO., LTD.		11
PROTAGONIST THERAPEUTICS, INC.		13
IONIS PHARMACEUTICALS, INC.		21
KYMERA THERAPEUTICS, INC.		22
QIAGEN N.V.		14
Average		16
Weighted average by Cap.		19